Axinn Promotes Attorneys Steinthal and Murata
January 29, 2013
JANUARY 29, 2013 – Axinn announced that Russell Steinthal, a member of the firm’s antitrust group, has been promoted to the position of partner. The firm also announced that Jason Murata, member of the firm’s intellectual property group, has been promoted to the position of counsel.
“We congratulate Russell and Jason for their accomplishments; they have made tremendous contributions to the firm,” said Managing Partner James Veltrop. “With rising talent in the antitrust and intellectual property practices, Axinn is poised to build on the firm’s reputation as a leader in these areas.”
Mr. Steinthal, who works from Axinn’s New York office, is a partner in the firm’s antitrust group and has experience with the full range of the group’s practice, including litigation, mergers and acquisitions, and corporate counseling. Mr. Steinthal has served as the lead antitrust attorney on a number of significant matters, and as a key in diverse industries including chemicals, packaging, retail, telecommunications and, most recently, several major patent acquisitions. He regularly counsels clients on a range of merger-related issues, including premerger notification requirements under the Hart-Scott-Rodino Act, the antitrust implications of merger agreement covenants and the regulatory review process, as well as non-merger issues.
Mr. Murata, who works from Axinn’s Hartford office, is a member of the firm’s intellectual property group. His practice focuses primarily on patent and trade secret litigation, with an emphasis in the mechanical, chemical and pharmaceutical arts, including patent litigation and consultation arising under Section 505(j) of the Federal Food, Drug and Cosmetic Act.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
IPWatchdog Sixth Annual Live Conference
Speaking Engagement
Intellectual Property
Squires Again Broadens Discretion for Post-Grant Proceedings
Axinn Viewpoints
Intellectual Property
ABA White Collar Crime Institute 2026
Speaking Engagement
Back to the Well: FDA’s Draft Guidance on New Clinical Investigation Exclusivity
Axinn Viewpoints
Intellectual Property
Mother, May I? The Use of Prior Approval Requirements in Merger Settlements
Podcast
Antitrust
The Curtain Rises Again on FTC Act Section 5
Axinn Viewpoints
Jeny Maier Named Finalist for Managing Partner of the Year in 2026 Women, Influence & Power in Law Awards
Awards & Recognitions
DOJ Serves Up a Statement of Interest with a Side of Fries
Axinn Viewpoints
Antitrust

